Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MORPHEUS study
2024-517763-22-00Phase 4Completed
- Sponsor
- UZ Leuven
- Start
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of morphine and midazolam, sponsored by UZ Leuven. Primary endpoints: Morphine and midazolam dosing and administration, Symptom control and 1 more. Started Jan 2025; status: completed.
02
Drugs
morphinemidazolam
Beyond the preview
Go deeper on 2024-517763-22-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-517763-22-00.